♟️ Thursday 29 January 2026 Thu, 29 Jan 2026

Avira Resources has completed its acquisition of the Mt Cattlin Gold Project, validating historical data and advancing plans for a significant drilling program in early 2026, backed by a $2.5 million capital raise.

Skylark Minerals has acquired a significant gold project portfolio in Côte d’Ivoire, including the flagship Zaranou Project with an inferred resource of 364,600 ounces. The company completed a A$10 million capital raise to fund upcoming exploration activities and has bolstered its technical team ahead of a busy 2026 drilling season.

Dimerix Limited has completed recruitment for its pivotal ACTION3 Phase 3 trial targeting a rare kidney disease, secured positive FDA feedback on trial endpoints, and reported a solid cash position of AU$38.5 million at the end of 2025.

6K Additive reported a strong finish to 2025 with a 25% revenue jump in Q4 and secured $31.4 million in IPO proceeds to fuel a fivefold production expansion. The company also landed a $27.4 million US government-backed loan, positioning it for accelerated growth in the additive manufacturing sector.

Sunrise Energy Metals advances its Syerston Scandium Project with a robust updated Ore Reserve supporting a 32-year mine life, alongside significant financing commitments and a strategic offtake option with Lockheed Martin.

Bannerman Energy reports steady progress on its Etango Uranium Project with key construction milestones met and a strong cash position, while uranium market fundamentals continue to strengthen. The company targets a positive Final Investment Decision within the next 6 to 12 months.

Zelira Therapeutics has raised nearly US$33 million to fund clinical trials for its HOPE 1 cannabinoid-based medicine targeting autism, while also benefiting from a $1.07 million R&D tax refund.

Indiana Resources has reported significant drilling results at its Minos Gold Project, including high-grade gold intersections up to 71 g/t, while also resolving a longstanding dispute with Tanzania. The company bolsters its exploration team and awaits assay results from nearby prospects.

Winsome Resources has agreed to be acquired by Li-FT Power Limited in a deal offering a substantial premium to shareholders, backed by strong lithium exploration results and strategic partnerships.

Ionic Rare Earths has advanced its global rare earths strategy with a key US partnership, significant UK government funding, and progress in Brazil and Uganda, positioning itself as a critical player in sustainable magnet recycling and heavy rare earth supply.

Archer Materials has made significant strides in its quantum computing and medical diagnostics programs, including improved carbon qubit readout and clinical-standard silicon biochips, while securing key partnerships and maintaining a strong cash position.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

Broken Hill Mines has delivered a standout December quarter with record mining rates at Rasp Mine, strong exploration results, and a robust financial position, setting the stage for accelerated growth in 2026.

Genesis Minerals delivered record gold production and a robust cash build in December 2025, while accelerating development at its Tower Hill project ahead of schedule.

Critical Resources Limited has secured a $1.75 million placement at market price, reinforcing investor confidence as it advances lithium, gold-antimony, and solid-state battery initiatives.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.

Genesis Minerals has restructured its executive team, appointing Raleigh Finlayson as Executive Chair and promoting Matthew Nixon to CEO, positioning the company for a significant growth phase.

CurveBeam AI reported steady device orders alongside a $4 million milestone payment from its China commercialisation deal, while progressing FDA clearance and robotic surgery system validation.

Arafura Rare Earths has raised A$481 million in equity funding and secured key government backing, advancing its Nolans Project towards a final investment decision in 2026.

Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.

Diablo Resources reports significant exploration advances at its Star Range silver-antimony and Phoenix copper projects in Utah, backed by a $2 million capital raise and new OTCQB listing to boost U.S. investor access.

INOVIQ Limited has completed a $10.2 million capital raise to accelerate development of its exosome-based ovarian cancer screening test and CAR-exosome therapeutics, alongside key leadership appointments and promising preclinical results.

Felix Gold Limited reports significant gold assay results from its NW Array prospect in Alaska, confirming extensive gold mineralisation alongside high-grade antimony. This comes as gold prices soar past US$5,000/oz, highlighting the project's strategic potential near Kinross Gold's Fort Knox mill.